Entries by drxadmin

Betaxol (Betaxolol)

Betaxol (Betaxolol) is a USFDA approved safe & selective β1-adrenergic receptor blocking agent. It lowers intraocular pressure by reducing the rate of production of aqueous humour. The onset of action can generally be noted within 30 minutes. Description Betaxolol is a USFDA-approved safe & selective β1 receptor blocker. It decreases aqueous humor production by blocking […]

Bepotas (Bepotastine Besilate)

Description Bepotastine is a direct H1-receptor antagonist and an inhibitor of the release of histamine from mast cells. Presentation Bepotas Sterile Eye Drops: Each ml contains Bepotastine Besilate INN 15 mg. Preservative: Sodium Perborate BP 0.01%. Indications Bepotas Sterile Ophthalmic Solution is indicated for the treatment of itching associated with signs and symptoms of allergic […]

Budison F HFA Inhaler (Budesonide & Formoterol Fumarate Dihydrate)

Budison F HFA inhaler is a combination of Budesonide & Formoterol Fumarate Dihydrate where Budesonide is an inhaled corticosteroid that exhibits potentglucocorticoid activity & Formoterol Fumarate Dihydrate is a long-acting selective ß2-adrenergic agonist (ß2-agonist) with a rapid onset of action. Description Budison F HFA inhaler is a combination of Budesonide & Formoterol Fumarate Dihydrate where […]

Budison F Arocap (Budesonide & Formoterol Fumarate Dihydrate)

Presentation Budison F®-100 Arocap: Each inhalation capsule contains Budesonide BP 100 μg and Formoterol Fumarate Dihydrate BP 6 μg.Budison F®-200 Arocap: Each inhalation capsule contains Budesonide BP 200 μg and Formoterol Fumarate Dihydrate BP 6 μg.Budison F®-400 Arocap: Each inhalation capsule contains Budesonide BP 400 μg and Formoterol Fumarate Dihydrate BP 12 μg. Indications Budison […]

Brinzopt (Brinzolamide)

Description Brinzolamide (Brinzopt) is a carbonic anhydrase inhibitor II (CA-II) that inhibits aqueous humor production to reduce elevated intraocular pressure. Presentation Brinzopt Sterile Ophthalmic Suspension: Each ml contains Brinzolamide USP 10 mg. Indications Brinzopt Sterile Ophthalmic Suspension is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Dosage […]

Budison Nebuliser Suspension (Budesonide)

Budison Nebuliser Suspension consists of Budesonide a corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity. Budesonide has approximately a 200-fold higher affinity for the glucocorticoid receptor and a 1000-fold higher topical anti-inflammatory potency than cortisol. Description Budison Nebuliser Suspension consists of Budesonide a corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity. Budesonide […]

Budison FG Inhaler (Budesonide, Formoterol & Glycopyrrolate)

Budison-FG HFA inhaler is a combination of Budesonide, Formoterol & Glycopyrrolate. Budesonide is a corticosteroid that exhibits potent glucocorticoid activity. Glycopyrrolate is a long-acting antimuscarinic agent which is often referred to as an anticholinergic & Formoterol is a long-acting selective ß2-adrenergic agonist (ß2-agonist) with a rapid onset of action. Description Budesonide is a corticosteroid that […]

Caftadin (Alcaftadine)

Description Alcaftadine is an H1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. In addition it antagonizes H2 & H4 receptors and thus provides antihistaminic actions. It also decreases chemotaxis and inhibits the activation of eosinophil. Presentation Caftadin Sterile Ophthalmic Solution: Each ml contains Alcaftadine INN 2.5 mg.Preservative: Sodium Perborate […]

Capecitin 500 (Capecitabine USP)

Capecitin 500 (Capecitabine) tablet contains 500 mg of Capecitabine which is an antimetabolite oral chemotherapy. Description Capecitabine is a fluoropyrimidine carbamate with antineoplastic activity. It is an orally administered systemic prodrug of 5′-deoxy-5-fluorouridine (5′-DFUR) which is converted to 5-fluorouracil (5-FU) by in vivo enzymatic conversion. 5-FU is then metabolized to 5-fluoro-2′-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate […]

Canalia (Dexlansoprazole)

Description Canalia (Dexlansoprazole) delayed release capsule has been characterized as a gastric Proton Pump Inhibitor (PPI) that blocks the final step of gastric acid production. It is the R-enantiomer of Lansoprazole (a racemic mixture of the R- and S-enantiomers). Presentation Composition:Canalia-30 Capsule: Each capsule contains Dexlansoprazole INN 30 mg asenteric coated pellets.Canalia-60 Capsule: Each capsule […]